Be a part of research

Routine screening for gambling-related harm

Routine screening for gambling disorder and gambling-related harm within mental health and drug and alcohol services: A feasibility and pilot study.

Study Status: Recruiting

Study Lead: Ella Tibbott. Please email researchinfo@nsft.nhs.uk for more info.

Summary: Questionnaire study for service users within NSFT. The purpose of the study is to ascertain how appropriate mental health and drug and alcohol services in England are for identifying and referring people experiencing gambling disorder and gambling-related harm. And to find out what the most optimal screening tools for determining prevalence of harmful gambling are in different services.

Who can be involved: All individuals aged 18 and above that are currently open to NSFT and are competent and willing to provide informed consent.

Inclusion Criteria:           

• Individuals Aged 18 and above.
• Open to any team within NSFT.
• Staff members at NSFT (for qualitative interviews).
• Competent and willing to provide informed consent.    

Exclusion Criteria:

• Where the individual has not given explicit consent to take part in the study.
• Where the individual is deemed not to be competent (e.g., under the influence of substances).
• Outside of stated age range.

What’s involved: Participants will fill in the questionnaire on a tablet/laptop, on paper or via telephone with a recruiting officer present. Questionnaire takes approximately 15 minutes to complete. Participants will be immediately signposted/ referred to relevant services/ pathways if they screen positive for harmful gambling.

Recruitment outside NSFT allowed: No

Recruitment end date: August 2025

Looking for:

• Individuals between the age of 16 and 65 open to NSFT.
• Have a diagnosis of non-affective psychosis; including schizophrenia, schizoaffective disorder, delusional disorder, psychosis not otherwise specified.
• Currently experiencing visual hallucinations within the last month.
• Be willing and able to provide their informed consent.

Information about the study:

The VISION-QUEST study  aims to develop and test a new questionnaire to understand people's beliefs about visual hallucinations. The questionnaire will also explore other physical and psychological factors thought to influence these experiences.

What's involved?

• Completing a pack of questionnaires in person or remotely.
• Participants will be paid £10 or equivalent in shopping voucher per pack they complete. 

Contact the research team:

• If you have any questions about the study, please contact the research team using the details below (Mon-Fri 9am to 5pm)
• Email: Researchinfo@nsft.nhs.uk
• Telephone: 01603 421397

 

 

 

 

 

Service users, families, carers and staff are being asked to help us to identify the top 10 research interests for adult community mental health care.

The research team has created a survey to use in a study as part of our research development objectives.

We are interested in knowing the issues and concerns that staff, service users and their families feel need to be explored by research.

This can include a wide range of topics, from mental health symptoms and day-to-day living challenges to support and treatment interventions, as well as the provision of mental health services.

The survey takes 10-15 minutes to complete and will contribute significantly to our understanding and improvement of adult community mental health care form a research perspective.

Complete the feedback form here. 

Email  gabriel.abotsie@nsft.nhs.uk  for more information about the study.

Looking for:

Individuals with a diagnosis of bipolar disorder and is a parent to at least one child between the ages of 4-10 years, with whom you have had at least 10 hours of contact a week.

Location:

Online

Information about the study:

The IBPI study is an online randomised control trial which aims to explore the effectiveness of an online intervention for parents with bipolar disorder, compared to treatment as usual on child behavioural and emotional difficulties.

IBPI delivers an interactive learning experience related to parenting and bipolar self-management techniques. It includes 9 modules covering areas such as managing mood changes and helping your child learn new skills.

What will taking part involve:

NSFT are being asked to help support recruitment by signposting service users directly to the trial team.

• You will need to register your interest on the trial information website.
• Screening interview with the trial team to confirm eligibility.
• Questionnaires about you, your child and your experience of parenting completed at 3 time points.
• Randomisation to receive the IBPI online intervention, plus current treatment, or to follow current treatment.

Contact the research team:

If you have any questions about the study, please contact the research team using the details below (Mon-Fri 9am to 5pm):

Email: Researchinfo@nsft.nhs.uk

Telephone: 01603 421397

Need more information? Willing to take part?

Lancaster University Website - www.lancs.ac.uk/spectrum/ibpi 

A randomised controlled trial of Acceptance and Commitment Therapy for older people with treatment resistant generalised anxiety disorder.

Looking for: People aged 60 and over who have a diagnosis of generalised anxiety disorder OR experiencing difficulties with chronic worry. Only open to recruit from teams where trained ACT Therapists are (NSFT Older Peoples Community Mental Health Teams: East and West Suffolk, and Norfolk: Norwich/North Care Group).

Location: In-person or online.

Information about the Study: The purpose of this trial is to see if a new form of talking therapy called Acceptance and Commitment Therapy (ACT) plus usual care can reduce anxiety in older people with chronic worry that has not improved after previous treatment compared to usual care alone. Acceptance and Commitment Therapy is a new form of talking therapy. It aims to help people learn how to live as best a life as they can with chronic worry, by helping them do things that are important and matter to them, alongside any worries or concerns they may have. If an individual is eligible and consents to the study, then they will be randomised to either the intervention group (ACT plus usual care) or the control group (usual care alone), there is a 50/50 chance of the individual receiving either ACT plus usual care or usual care alone.

 

What will taking part involve: Visits can be either face to face (home or clinic), telephone or online videocall. There is an initial Consent and Screening visit, followed by Baseline and further visits at 6 and 12 months. If randomised to the intervention arm, the participant will be offered Acceptance and Commitment Therapy (ACT) plus their usual care. ACT includes up to 14, 1-hour sessions of therapy. The sessions can take place in person or by video or phone call. ACT includes working with a therapist to develop an understanding of the difficulties the person has been experiencing.

Contact the research team

If you have any questions about the study, please contact the research team using the below email address:

Researchinfo@nsft.nhs.uk

 

Looking for: People aged 16 to 25 years of age who either have an eating disorder (or think they may have one), or have no history of an eating disorder (healthy volunteer).

Location: Online

Information about the study

STORY is exploring the diverse experiences of young people with eating disorders. How do symptoms progress over time? What helps or hinders recovery? This information will allow us to deliver more personalised and effective interventions for young people with eating disorders in the future. 

What will taking part involve: Participants in this study will complete online surveys and tasks on a computer or smartphone at different times, download two apps onto their smartphone and optionally wear a device on their finger to measure heart rate and sleep.

Contact the research team

If you have any questions about the study, please contact the research team using the details below (Mon-Fri 9am to 5pm):

Researchinfo@nsft.nhs.uk

01603 421397

Need more information? Willing to take part?

 

Looking for: People aged 16 and above who have experienced, or are experiencing any eating disorder and live in England.

Location: Online

Info about the study

What will taking part involve? Taking part in this study will involve completing some questions which will ask about your demographics (e.g. age, gender and employment situation), emotional wellbeing, health and lifestyle, personality and experiences of an eating disorder. Following this you will be sent a kit to take a saliva sample, which you will then need to send back to the study team via pre-paid post.

Contact the research team

If you have any questions about the study, please contact the research team using the below email address:

Researchinfo@nsft.nhs.uk

Need more information? Willing to take part?

For further information see: https://edgiuk.org/ 

COBALT: COmBining memantine And cholinesterase inhibitors in Lewy body dementia Treatment

A randomised controlled trial assessing whether adding memantine to cholinesterase inhibitors improves the overall health and functioning of people with Lewy Body or Parkinson's Dementia.

Who can take part:

Inclusion criteria (answers must be yes to take part):

• People with a diagnosis of probable Lewy Body Dementia or probable Parkinson's Dementia
• Aged 55+
• Taking a cholinesterase inhibitor for at least 12 weeks
• Sufficient knowledge of the English language or support to understand the Participant Information Sheet and complete the trial assessments

What it involves: If you are interested in taking part, you will be contacted by a member of our research team who will outline the study for you, answer any questions you may have and check your eligibility. Involvment in the study includes being randomised to receive either memantine or a placebo, completion of a weekly diary, 12 months involvement in the study and regular outcome measures being taken for both participant and their trial partner (caregiver).

How to get involved: Contact us via email at Researchinfo@nsft.nhs.uk or via telephone on 01603 421397 to express interest in taking part.

Age 16 +

Duration: Up to one hour

Location: One off online questionnaire and optional test

GLAD stands for the genetic links to anxiety and depression. The study is a project set up to support research exploring risk factors for depression and/or anxiety.

The GLAD study aims to better understand depression and anxiety to find more effective treatments. It hopes to improve the lives of people experiencing these disorders.

GLAD is a national study with its own specialist website. Please remember if you found out about the study from Norfolk and Suffolk NHS Foundation Trust then be sure to put that when asked to ‘select the NHS trust, GP, talking therapy service or other healthcare provider’.

Register your interest on the GLAD website

PPIP2 — Prevalence of Pathogenic Antibodies in Psychosis

Looking for: 

Individuals between the age of 16-70 years who are experiencing a current episode of psychosis lasting less than 2 years. This can be a first episode or relapse.

Information about the study

The aim is to assess the number of patients experiencing psychosis that also have anti-neuronal membrane antibodies which might cause their illness.

What will taking part involve:

• One-off visit.
• Questionnaires regarding demographic information, previous history of psychotic illness and length of current episode of psychosis symptoms.
• Blood sample.

Contact the research team

If you have any questions about the study, please contact the research team using the details below (Mon-Fri 9am to 5pm)

Email: Researchinfo@nsft.nhs.uk

Telephone: 01603 421397

Need more information? Willing to take part?

For further information visit the national website and choose Norfolk & Suffolk NHS Foundation Trust